These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26431103)

  • 1. Dissolution profiles of perindopril and indapamide in their fixed-dose formulations by a new HPLC method and different mathematical approaches.
    Gumieniczek A; Mączka P; Komsta Ł; Pietraś R
    Acta Pharm; 2015 Sep; 65(3):235-52. PubMed ID: 26431103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of spectrophotometric and an LC method for the determination perindopril and indapamide in pharmaceutical formulations.
    Erk N
    J Pharm Biomed Anal; 2001 Aug; 26(1):43-52. PubMed ID: 11451641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of indapamide, perindopril and its active metabolite perindoprilat in human plasma using UPLC-MS/MS method.
    Zheng X; Gao H; Cui X; Zhang Y; Chen R; Wang Y; Lauruol P; Wang H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Apr; 1169():122585. PubMed ID: 33706186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a stability-indicating assay method for simultaneous determination of perindopril and indapamide in combined dosage form by reversed-phase high-performance liquid chromatography.
    Jogia H; Khandelwal U; Gandhi T; Singh S; Modi D
    J AOAC Int; 2010; 93(1):108-15. PubMed ID: 20334172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Validated HPLC Method for Simultaneous Determination of Perindopril Arginine, Amlodipine, and Indapamide: Application in Bulk and in Different Pharmaceutical Dosage Forms.
    El-Bagary RI; Elkady EF; Mowaka S; Attallah MA
    J AOAC Int; 2017 Jul; 100(4):992-999. PubMed ID: 28168948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro-in vivo correlations for three different commercial immediate-release indapamide tablets.
    Yaro P; He X; Liu W; Xun M; Ma Y; Li Z; Shi X
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1670-6. PubMed ID: 24102615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UHPLC-UV Method for Simultaneous Determination of Perindopril Arginine and Indapamide Hemihydrate in Combined Dosage Form: A Stability-Indicating Assay Method.
    Al-Tannak NF
    Sci Pharm; 2018 Feb; 86(1):. PubMed ID: 29470453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a dissolution method with HPLC analysis for lasofoxifene tartrate low dose tablets.
    Space JS; Opio AM; Nickerson B; Jiang H; Dumont M; Berry M
    J Pharm Biomed Anal; 2007 Sep; 44(5):1064-71. PubMed ID: 17560750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of drug-carrier interactions in quaternary powder mixtures containing perindopril tert-butylamine and indapamide.
    Voelkel A; Milczewska K; Teżyk M; Milanowski B; Lulek J
    Int J Pharm; 2016 Apr; 503(1-2):29-35. PubMed ID: 26924356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chiral liquid chromatography resolution and stereoselective pharmacokinetic study of indapamide enantiomers in rats.
    Du B; Pang L; Li H; Ma S; Li Y; Jia X; Zhang Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():88-91. PubMed ID: 23831701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
    Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D
    J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into Dissolution and Solution Chemistry of Multidrug Formulations of Antihypertensive Drugs.
    El Sayed M; Alhalaweh A; Bergström CAS
    Mol Pharm; 2020 Oct; 17(10):4018-4028. PubMed ID: 32870692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients.
    Mourad JJ; Le Jeune S
    Curr Med Res Opin; 2009 Sep; 25(9):2271-80. PubMed ID: 19627177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure and metabolic efficacy of fixed-dose combination of perindopril and indapamide in everyday practice.
    Farsang C;
    Blood Press; 2013 Sep; 22 Suppl 1():3-10. PubMed ID: 23163322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of independent component analysis on Raman images of a pharmaceutical drug product: pure spectra determination and spatial distribution of constituents.
    Boiret M; Rutledge DN; Gorretta N; Ginot YM; Roger JM
    J Pharm Biomed Anal; 2014 Mar; 90():78-84. PubMed ID: 24333706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Dissolution Profile of Antihypertensive Mixture: Comparison Between Multivariate Methods and Statistical and Graphical Representation of Different Univariate Spectrophotometric Data.
    Magdy R; Hemdan A; Farouk M; Fares NV
    J AOAC Int; 2023 May; 106(3):624-635. PubMed ID: 36420987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
    Gosse P
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension.
    Laurent S
    J Hypertens Suppl; 2001 Nov; 19(4):S9-14. PubMed ID: 11848262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A selective HPLC method for the determination of indapamide in human whole blood: application to a bioequivalence study in Chinese volunteers.
    Hang TJ; Zhao W; Liu J; Song M; Xie Y; Zhang Z; Shen J; Zhang Y
    J Pharm Biomed Anal; 2006 Jan; 40(1):202-5. PubMed ID: 16111851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of microcalorimetry and HPLC for the determination of degradation kinetics and thermodynamic parameters of Perindopril Erbumine in aqueous solutions.
    Simoncic Z; Roskar R; Gartner A; Kogej K; Kmetec V
    Int J Pharm; 2008 May; 356(1-2):200-5. PubMed ID: 18304767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.